109 related articles for article (PubMed ID: 3527416)
1. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
Noworolska A; Harłozińska-Szmyrka A; Richter R
Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
[TBL] [Abstract][Full Text] [Related]
2. Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.
Noworolska A; Slesak B; Harłonzińska A; Richter R
Neoplasma; 1991; 38(1):57-62. PubMed ID: 2011210
[TBL] [Abstract][Full Text] [Related]
3. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A; Harłozińska A; Richter R; Brodzka W
Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
[TBL] [Abstract][Full Text] [Related]
4. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
[TBL] [Abstract][Full Text] [Related]
5. Relationship between myelomonocytic, myeloid and nonspecific cross-reacting (NCA) antigens during myelocytic cell differentiation.
Harłozińska A; Noworolska A; Majdic O; Richter R; Kotlarek-Haus S
Br J Cancer; 1987 Dec; 56(6):787-90. PubMed ID: 2449236
[No Abstract] [Full Text] [Related]
6. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
7. Presence of NCA (nonspecific cross-reacting antigen) in the cells of the human granulocyte series.
Burtin P; Flandrin G; Fondaneche MC
Blood Cells; 1980; 6(2):263-78. PubMed ID: 6991029
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
Takasaki Y; Robinson WA; Tan EM
J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
[TBL] [Abstract][Full Text] [Related]
9. Cytophotometry of granulocytes in chronic granulocytic leukemia patients. Part I. Cell cycle distribution, S-phase transition and quantitative cytochemistry.
Kotelnikov VM; Lishmanova NG; Khoroshko ND; Dultsyna SM; Alieva TM; Khrust YuR ; Kozinets GI
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):585-95. PubMed ID: 2448196
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
Schölzel C; Löwenberg B
Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
[TBL] [Abstract][Full Text] [Related]
11. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
Maliszewski CR; Ball ED; Graziano RF; Fanger MW
J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
[TBL] [Abstract][Full Text] [Related]
13. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
[TBL] [Abstract][Full Text] [Related]
14. [Electrophoretic heterogeneity of peripheral blood granulocytes in patients with chronic myeloid leukemia].
Slivinskiĭ GG; Il'iasova MN; Kozhanova SV
Eksp Onkol; 1987; 9(6):67-70. PubMed ID: 3481334
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific cross-reacting antigen as a marker of myelocytic leukemias in individual stages of myelocytic cell differentiation.
Harłozińska A; Noworolska A; Richter R
Haematol Blood Transfus; 1985; 29():194-6. PubMed ID: 3861480
[No Abstract] [Full Text] [Related]
16. In vitro culture and ultrastructure analysis of peripheral blood cells separated by discontinuous albumin density gradient during blast crisis of chronic granulocyte leukemia.
Astaldi G; Bagnara GP; Biagini G; Baccarani M; Brunelli MA; Laschi R
Arch Geschwulstforsch; 1981; 51(1):63-8. PubMed ID: 6942793
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
